VTA: FDA CTP's Actions Undermine Public Health

Regulations by 2FIRSTS.ai
Jan.22.2024
VTA: FDA CTP's Actions Undermine Public Health
The US FDA reportedly denies marketing orders for Suorin and blu PLUS+ e-cigarettes, drawing criticism from the VTA.

On January 19th, Tony Abboud, the Executive Director of the Vapor Technology Association (VTA), announced that the U.S. Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Suorin and blu PLUS+ e-cigarettes. This decision by the FDA and the Center for Tobacco Products (CTP) is seen as part of their ongoing efforts to effectively ban e-cigarettes in the United States.

 

Abdullah states that the FDA continually emphasizes that e-cigarette manufacturers have not provided "sufficient scientific evidence" in their PMTA applications. However, the FDA refuses to address the Reagan-Udall Foundation's fundamental criticism of the entire regulatory process, which is that the FDA has not clearly outlined what needs to be proven for something to be considered "appropriate for the protection of public health (APPH)," nor how it interprets what APPH entails.

 

Abdul believes that not objectively defining and using standards to refuse marketing authorization for critical smoking cessation and harm reduction products is a serious overreach for any government agency that follows a scientific mission.

 

The court found that the process had become "arbitrary and capricious" in practice, with CTP leadership determining standards based on specific circumstances. Meanwhile, the company was simply attempting to do the right thing by adhering to the PMTA process established by the FDA.

 

He continued, "Most notably, CTP claims to have denied Suorin's PMTA because its product promotes 'sustained use and progression' of dependence. If this is the standard, then every nicotine product would fail CTP's bizarre criteria, as nicotine is addictive, furthering CTP's implementation of a ban on less harmful nicotine."

 

"The actions taken by the FDA and CTP today do not contribute to the protection of public health or to assisting Americans who smoke. VTA once again urges CTP to reverse its malicious behavior and restore the scientific integrity of its regulatory and decision-making processes. Enough is enough," said Abdu.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Chill Brands and SYP Global Develop Novel Nicotine Delivery System, Expected to Launch Within 12 Months
Chill Brands and SYP Global Develop Novel Nicotine Delivery System, Expected to Launch Within 12 Months
Chill Brands Group has formed a strategic partnership with SYP Global, which is developing a heating-free nicotine delivery technology designed to reduce harmful by-products. Chill Brands will support SYP’s market entry through its distribution network, though commercial launch is expected within 12 months with no immediate revenue impact.
Sep.09
Reuters: BAT to Launch Synthetic Nicotine Vape Vuse One in U.S., Hitting Shelves in Three States from Late September
Reuters: BAT to Launch Synthetic Nicotine Vape Vuse One in U.S., Hitting Shelves in Three States from Late September
British American Tobacco (BAT) plans to pilot sales of its disposable synthetic nicotine vape, Vuse One, in the United States, with launches expected in South Carolina, Florida, and Georgia in late September. The product has not yet received approval from the U.S. Food and Drug Administration (FDA). According to Reuters, this move marks a major shift in BAT’s stance after years of opposing the sale of unauthorized vapes. The company said the product will be distributed through major national ret
Aug.21 by 2FIRSTS.ai
Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways
Special Report | Anti-Vaping Campaign in the Baltics Goes Sideways
2Firsts analyzes vaping regulations across the Baltic states. Following Latvia’s flavor ban, tax revenues fell and the black market expanded, while similar measures in Estonia and Lithuania have also failed to deliver results. The region’s anti-vaping policies are now triggering market imbalance and policy reassessment.
Oct.13
Spain's Proposed E-cigarette and Nicotine Pouch Restrictions Spark EU Debate
Spain's Proposed E-cigarette and Nicotine Pouch Restrictions Spark EU Debate
Lead: Spain's proposed e-cigarette and nicotine pouch restrictions face strong opposition from seven EU countries and the European Commission.
Aug.21 by 2FIRSTS.ai
Research Review | Between Harm Reduction and Environmental Care: Innovation, Regulation, and New Environmental Challenges in Argentina and South America
Research Review | Between Harm Reduction and Environmental Care: Innovation, Regulation, and New Environmental Challenges in Argentina and South America
This article is based on research materials provided by an Argentine team and edited by 2Firsts. It reviews the latest developments in South America’s NGP market, covering regulatory differences, environmental challenges, and the balance between harm reduction and sustainability.
Aug.25
Two South African students had their scholarships revoked for vaping; court rules the school's punishment invalid
Two South African students had their scholarships revoked for vaping; court rules the school's punishment invalid
Two South African students win court ruling against school's excessive e-cigarette punishment, violating "no double jeopardy" principle.
Sep.15 by 2FIRSTS.ai